Ireland Fears Shortage Of Medicines Co-Labeled With UK Following Brexit

By encouraging and facilitating the joint labeling of medicines with the UK, Ireland has ensured the availability of the necessary human and veterinary medicines despite its small market size. But Brexit is causing concern that medicines for smaller patient populations may not be commercially viable if they have to be packaged separately for the Irish market.